<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ISOPTO CETAMIDE- sulfacetamide sodiumÂ solution/ dropsÂ </strong><br><strong>CETAMIDE- sulfacetamide sodiumÂ ointmentÂ </strong><br>Alcon<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="description"></a><a name="section-2"></a><p></p>
<h1> DESCRIPTION</h1>
<p class="First">ISOPTO CETAMIDEÂ® (sulfacetamide sodium ophthalmic solution USP) 15% and CETAMIDEâ„¢ (sulfacetamide sodium ophthalmic ointment, USP) 10% are sterile topical antibacterial agents for ophthalmic use.  The active ingredient is represented by the following structural formula:</p>
<div class="Figure"><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5a5d8fee-b42a-4f0c-a508-75c7c71bedb4&amp;name=Cetamide-01.jpg"></div>
<p>Chemical name:  N-Sulfanilylacetamide monosodium salt monohydrate.</p>
<p><span class="Bold">Each mL of solution contains</span>:  <span class="Bold">Active</span>:  Sulfacetamide sodium 15% (150 mg/mL).  <span class="Bold">Preservative:</span>  Methylparaben 0.05%, Propylparaben 0.01%.  <span class="Bold">Vehicle:  </span>0.5% Hydroxyporpyl Methylcellulose 2910 (viscosity type, 4000 cps).  <span class="Bold">Inactive:</span>  Sodium Thiosulfate 0.3%, Dibasic Sodium Phosphate and/or Monobasic Sodium Phosphate (to adjust pH), Purified Water.</p>
<p>pH range between 7.0 and 7.8Â Â Â Â Â Â Â  DM-02</p>
<p><span class="Bold">Each gram of ointment contains:  Active:</span>  Sulfacetamide Sodium 10% (100 mg).  <span class="Bold">Preservatives:</span>  Methylparaben 0.05%, Propylparaben 0.01%.  <span class="Bold">Inactive:  </span>White Petrolatum, Anhydrous Liquid Lanolin, Mineral Oil.Â Â Â Â Â  DM-00</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="clinical-pharmacology"></a><a name="section-3"></a><p></p>
<h1> CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="clinical-pharmacology-microbiology"></a><a name="section-3.1"></a><p></p>
<h2> Microbiology</h2>
<p class="First">The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all.  Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase.  Resistant <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> have altered dihydropteroate synthetase with reduced affinity for sulfonamides or produce increased quantities of aminobenzoic acid.</p>
<p>Topically applied sulfonamides are considered active against susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following common bacterial eye pathogens:  <span class="Italics">Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (</span>viridans<span class="Italics"></span> group<span class="Italics">), Haemophilus influenzae, Klebsiella </span>species<span class="Italics">, </span>and<span class="Italics"> Enterobacter </span>species<span class="Italics">.</span></p>
<p>Topically applied sulfonamides do not provide adequate coverage against <span class="Italics">Neisseria </span>species, <span class="Italics">Serratia marcescens</span> and <span class="Italics">Pseudomonas aeruginosa</span>.  A significant percentage of Staphylococcal isolates are completely resistant to sulfa drugs.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="indications-and-usage"></a><a name="section-4"></a><p></p>
<h1> INDICATIONS AND USAGE</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="indications-and-usage-solution"></a><a name="section-4.1"></a><p></p>
<h2> Solution</h2>
<p class="First">For the treatment of <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> and other superficial ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma:  <span class="Italics">Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (</span>viridans<span class="Italics"></span> group), <span class="Italics">Haemophilus influenzae, Klebsiella </span>species, and <span class="Italics">Enterobacter </span>species.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="solution-ointment"></a><a name="section-4.2"></a><p></p>
<h2> Ointment</h2>
<p class="First">For the treatment of <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> and other superficial ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to susceptible microorganisms.  Topically applied sulfonamides do not provide adequate coverage against <span class="Italics">Neisseria</span> species, <span class="Italics">Serratia marcescens</span> and <span class="Italics">Pseudomonas aeruginosa.</span>  A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.  </p>
</div>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="contraindications"></a><a name="section-5"></a><p></p>
<h1> CONTRAINDICATIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to sulfonamides or to any ingredient of the preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="warnings"></a><a name="section-6"></a><p></p>
<h1> WARNINGS</h1>
<p class="First">FOR TOPICAL EYE USE ONLY â€“ NOT FOR INJECTION.  FATALITIES HAVE OCCURRED, ALTHOUGH RARELY, DUE TO SEVERE REACTIONS TO SULFONAMIDES INCLUDING <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">STEVENS-JOHNSON SYNDROME</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">TOXIC EPIDERMAL NECROLYSIS</span>, FULMINANT <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">HEPATIC NECROSIS</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">AGRANULOCYTOSIS</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">APLASTIC ANEMIA</span> AND OTHER <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">BLOOD DYSCRASIAS</span>.  Sensitizations may recur when a sulfonamide is readministered, irrespective of the route of administration.  Sensitivity reactions have been reported in individuals with no prior history of sulfonamide <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>.  At the first sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> or other serious reaction, discontinue use of this preparation.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="precautions"></a><a name="section-7"></a><p></p>
<h1> PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="precautions-general"></a><a name="section-7.1"></a><p></p>
<h2> General</h2>
<p class="First">Prolonged use of topical anti-bacterial agents may give rise to overgrowth of nonsusceptible organisms including fungi.  <span class="product-label-link" type="condition" conceptid="4207042" conceptname="Viral resistance">Bacterial resistance</span> to sulfonamides may also develop.  Ophthalmic ointments may retard corneal <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> healing.  The effectiveness of sulfonamides may be reduced by the para-aminobenzoic acid present in purulent exudates.  Sensitization may recur when a sulfonamide is readministered irrespective of the route of administration, and cross-sensitivity between different sulfonamides may occur.  At the first sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, increase in <span class="product-label-link" type="condition" conceptid="4145093" conceptname="Purulent discharge">purulent discharge</span>, or aggravation of <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span> or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, the patient should discontinue use of the medication and consult a physician (see <span class="Underline"><a href="#warnings">WARNINGS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="general-information-for-patients"></a><a name="section-7.2"></a><p></p>
<h2> Information for Patients</h2>
<p class="First">To avoid contamination, do not touch tip of container to eye, eyelid or any surface.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="information-for-patients-drug-interactions"></a><a name="section-7.3"></a><p></p>
<h2> Drug Interactions</h2>
<p class="First">Sulfacetamide preparations are incompatible with silver preparations.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="drug-interactions-carcinogenesis-mutagenesis-impairment-of-fertility"></a><a name="section-7.4"></a><p></p>
<h2> Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No studies have been conducted in animals or in humans to evaluate the possibility of these effects with ocularly administered sulfacetamide.  Rats appear to be especially susceptible to the goitrogenic effects of sulfonamides, and long-term oral administration of sulfonamides has resulted in thyroid malignancies in these animals.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="carcinogenesis-mutagenesis-impairment-of-fertility-pregnancy"></a><a name="section-7.5"></a><p></p>
<h2> Pregnancy</h2>
<p class="First">Pregnancy Category C.  Animal reproduction studies have not been conducted with sulfonamide ophthalmic preparations.  <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">Kernicterus</span> may occur in the newborn as a result of treatment of a pregnant woman at term with orally administered sulfonamides.  This product should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="pregnancy-nursing-mothers"></a><a name="section-7.6"></a><p></p>
<h2> Nursing Mothers</h2>
<p class="First">Systemically administered sulfonamides are capable of producing <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">kernicterus</span> in infants of lactating women.  Because of the potential for the development of <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">kernicterus</span> in neonates, a decision should be made whether to discontinue nursing or discontinue the drug taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="nursing-mothers-pediatric-use"></a><a name="section-7.7"></a><p></p>
<h2> Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients below the age of two months have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="adverse-reactions"></a><a name="section-8"></a><p></p>
<h1> ADVERSE REACTIONS</h1>
<p class="First">Bacterial and fungal <span class="product-label-link" type="condition" conceptid="373202" conceptname="Corneal ulcer">corneal ulcers</span> have developed during treatment with sulfonamide ophthalmic preparations.  The most frequently reported reactions are local irritation, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> and burning.  Less commonly reported reactions include non-specific <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival hyperemia</span>, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infections</span> and <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>.  Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span>, fulminant <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span>, and other <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">blood dyscrasias</span> (see <span class="Underline"><a href="#warnings">WARNINGS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="dosage-and-administration"></a><a name="section-9"></a><p></p>
<h1> DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="dosage-and-administration-for-<span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>-and-other-superficial-ocular-<span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>"></a><a name="section-9.1"></a><p></p>
<h2> For <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> and other superficial ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>:</h2>
<p class="First"><span class="Italics">Solution:  </span>Instill one or two drops into the conjunctival sac(s) of the affected eye(s) every two to three hours initially.  Dosages may be tapered by increasing the time interval between doses as the condition responds.  The usual duration of treatment is seven to ten days.</p>
<p><span class="Italics">Ointment:</span>  Apply a small amount (approximately one-half inch ribbon) into the conjunctival sac(s) of the affected eye(s) every three to four hours and at bedtime.  Dosages may be tapered by increasing the time interval between doses as the condition responds.  The ointment may be used as adjunct to the solution.  The usual duration of treatment is seven to ten days.</p>
<p>How to apply CETAMIDEâ„¢ Ointment:</p>
<ol>
<li>Tilt your head back.</li>
<li>Place a finger on your cheek just under your eye and gently pull down until a â€œVâ€? pocket is formed between your eyeball and your lower lid.</li>
<li>Place a small amount (about Â½ inch) of CETAMIDEâ„¢ Ointment in the â€œVâ€? pocket.  Do not let the tip of the tube touch your eye.</li>
<li>Look downward before closing your eye.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="for-<span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>-and-other-superficial-ocular-<span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>-for-trachoma"></a><a name="section-9.2"></a><p></p>
<h2> For Trachoma:</h2>
<p class="First"><span class="Italics">Solution:  </span>Instill two drops into the conjunctival sac(s) of the affected eye(s) every two hours.  Topical administration must be accompanied by systemic administration.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="how-supplied"></a><a name="section-10"></a><p></p>
<h1> HOW SUPPLIED</h1>
<p class="First">Solution in 5mL and 15mL plastic DROP-TAINERÂ® Dispensers.  Ointment in 3.5g ophthalmic tubes:</p>
<p>5 mL solution Â  -  NDC 0998-0522-05</p>
<p>15 mL solution  - NDC 0998-0522-15</p>
<p>3.5 g ointmentÂ  - NDC 0065-0526-35</p>
<div class="Section" data-sectionCode="44425-7">
<a name="how-supplied-storage"></a><a name="section-10.1"></a><p></p>
<h2> STORAGE</h2>
<p class="First">Solution â€“ Store at 8Â° - 24Â°C (46Â° - 75Â°F).  Protect from light.  Do not use if solution is discolored (dark brown).  Sulfonamide solutions, on long standing, will darken in color and should be discarded.</p>
<p>Ointment â€“ Store at 8Â° - 27Â°C (46Â°-80Â°F).</p>
<p><span class="Bold">CAUTION:  </span>Federal (USA) law prohibits dispensing without prescription.</p>
<p><span class="Bold">341035</span></p>
<p><span class="Bold">Rev:  January 1995</span></p>
<p><span class="Bold">AlconÂ®</span></p>
<p><span class="Italics"><span class="Bold">OPHTHALMIC</span></span></p>
<p><span class="Bold">ALCON LABORATORIES, INC.</span></p>
<p><span class="Bold"> Fort Worth,  TX   76134  USA</span></p>
<p><span class="Bold">Printed in  USA</span></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ISOPTO CETAMIDEÂ 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0998-0522</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>sulfacetamide sodium</strong> (sulfacetamide) </td>
<td class="formItem"></td>
<td class="formItem">150Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>methylparaben</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>propylparaben</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>hydroxypropyl methylcellulose 2910</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium thiosulfate</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>dibasic sodium phosphate</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>monobasic sodium phosphate</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0998-0522-05</td>
<td class="formItem">5 mL in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0998-0522-15</td>
<td class="formItem">15 mL in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CETAMIDEÂ 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium ointment</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0065-0526</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>sulfacetamide sodium</strong> (sulfacetamide) </td>
<td class="formItem"></td>
<td class="formItem">100Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>methylparaben</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>propylparaben</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>white petrolatum</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>anhydrous liquid lanolin</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>mineral oil</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0065-0526-35</td>
<td class="formItem">3.5 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Alcon</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 11/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>EEF99480-F750-876E-15A9-E4323C8D7190</div>
<div>Set id: 5a5d8fee-b42a-4f0c-a508-75c7c71bedb4</div>
<div>Version: 1</div>
<div>Effective Time: 20061120</div>
</div>
</div>Â <div class="DistributorName">Alcon</div></p>
</body></html>
